What employers need to know about Zepbound's expanded use in obstructive sleep apnea.
Health professionals who treat patients with diabetes report three advantages of continuous glucose monitoring when compared to a traditional glucose meter.
Read to learn how employers can strategically manage their formulary strategy to reduce costs and put employees first.
Health care spending is projected to rise 8% in 2025, driven by increased use of GLP-1 drugs for diabetes and obesity.
Patient-centered diabetes program drives significant A1C reduction in just 6 months.
An Educational Resource from True Rx Health Strategists